Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Free Radic Biol Med ; 106: 134-147, 2017 05.
Artículo en Inglés | MEDLINE | ID: mdl-28189848

RESUMEN

Landomycin E (LE) is an angucycline antibiotic produced by Streptomyces globisporus. Previously, we have shown a broad anticancer activity of LE which is, in contrast to the structurally related and clinically used anthracycline doxorubicin (Dx), only mildly affected by multidrug resistance-mediated drug efflux. In the present study, cellular and molecular mechanisms underlying the anticancer activity of landomycin E towards Jurkat T-cell leukemia cells were dissected focusing on the involvement of radical oxygen species (ROS). LE-induced apoptosis distinctly differed in several aspects from the one induced by Dx. Rapid generation of both extracellular and cell-derived hydrogen peroxide already at one hour drug exposure was observed in case of LE but not found before 24h for Dx. In contrast, Dx but not LE induced production of superoxide radicals. Mitochondrial damage, as revealed by JC-1 staining, was weakly enhanced already at 3h LE treatment and increased significantly with time. Accordingly, activation of the intrinsic apoptosis pathway initiator caspase-9 was not detectable before 12h exposure. In contrast, cleavage of the down-stream caspase substrate PARP-1 was clearly induced already at the three hour time point. Out of all caspases tested, only activation of effector caspase-7 was induced at this early time points paralleling the LE-induced oxidative burst. Accordingly, this massive cleavage of caspase-7 at early time points was inhibitable by the radical scavenger N-acetylcysteine (NAC). Additionally, only simultaneous inhibition of multiple caspases reduced LE-induced apoptosis. Specific scavengers of both H2O2 and OH• effectively decreased LE-induced ROS production, but only partially inhibited LE-induced apoptosis. In contrast, NAC efficiently blocked both parameters. Summarizing, rapid H2O2 generation and a complex caspase activation pattern contribute to the antileukemic effects of LE. As superoxide generation is considered as the main cardiotoxic mechanism of Dx, LE might represent a better tolerable drug candidate for further (pre)clinical development.


Asunto(s)
Aminoglicósidos/administración & dosificación , Antibióticos Antineoplásicos/administración & dosificación , Células Jurkat/metabolismo , Leucemia/tratamiento farmacológico , Estrés Oxidativo/efectos de los fármacos , Acetilcisteína/administración & dosificación , Apoptosis/efectos de los fármacos , Caspasa 7/metabolismo , Caspasa 9/metabolismo , Doxorrubicina/administración & dosificación , Humanos , Peróxido de Hidrógeno/toxicidad , Células Jurkat/efectos de los fármacos , Células Jurkat/patología , Leucemia/metabolismo , Leucemia/patología , Mitocondrias/efectos de los fármacos , Mitocondrias/patología , Poli(ADP-Ribosa) Polimerasa-1/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Streptomyces/química , Superóxidos/toxicidad
2.
Cancer Prev Res (Phila) ; 10(2): 153-160, 2017 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-27923802

RESUMEN

Xanthohumol (XN) is a hop flavonoid contained in beers and soft drinks. In vitro and animal studies indicated that XN has DNA and cancer protective properties. To find out if it causes DNA protective effects in humans, an intervention trial was conducted in which the participants (n = 22) consumed a XN containing drink (12 mg XN/P/d). We monitored prevention of DNA damage induced by representatives of major groups of dietary carcinogens [i.e., nitrosodimethylamine (NDMA) benzo(a)pyrene (B(a)P) and the heterocyclic aromatic amine 2-amino-3-methylimidazo[4,5-f]quinoline (IQ)]. Lymphocytes were collected before, during, and after the intervention and incubated with the carcinogens and with human liver homogenate (S9). We found substantial reduction of B(a)P and IQ (P < 0.001 for both substances) induced DNA damage after consumption of the beverage; also, with the nitrosamine a moderate, but significant protective effect was found. The results of a follow-up trial (n = 10) with XN pills showed that the effects are caused by the flavonoid and were confirmed in γH2AX experiments. To elucidate the underlying mechanisms we measured several parameters of glutathione related detoxification. We found clear induction of α-GST (by 42.8%, P < 0.05), but no alteration of π-GST. This observation provides a partial explanation for the DNA protective effects and indicates that the flavonoid also protects against other carcinogens that are detoxified by α-GST. Taken together, our findings support the assumption that XN has anticarcinogenic properties in humans. Cancer Prev Res; 10(2); 153-60. ©2016 AACR.


Asunto(s)
Carcinógenos/toxicidad , Daño del ADN , Flavonoides/farmacología , Linfocitos/efectos de los fármacos , Propiofenonas/farmacología , Adulto , Estudios Cruzados , Dieta , Femenino , Humanos , Masculino
3.
PLoS One ; 8(2): e56308, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23457546

RESUMEN

Overexpression of ecotropic viral integration site 1 (EVI1) is associated with aggressive disease in acute myeloid leukemia (AML). Despite of its clinical importance, little is known about the mechanism through which EVI1 confers resistance to antileukemic drugs. Here, we show that a human myeloid cell line constitutively overexpressing EVI1 after infection with a retroviral vector (U937_EVI1) was partially resistant to etoposide and daunorubicin as compared to empty vector infected control cells (U937_vec). Similarly, inducible expression of EVI1 in HL-60 cells decreased their sensitivity to daunorubicin. Gene expression microarray analyses of U937_EVI1 and U937_vec cells cultured in the absence or presence of etoposide showed that 77 and 419 genes were regulated by EVI1 and etoposide, respectively. Notably, mRNA levels of 26 of these genes were altered by both stimuli, indicating that EVI1 regulated genes were strongly enriched among etoposide regulated genes and vice versa. One of the genes that were induced by both EVI1 and etoposide was CDKN1A/p21/WAF, which in addition to its function as a cell cycle regulator plays an important role in conferring chemotherapy resistance in various tumor types. Indeed, overexpression of CDKN1A in U937 cells mimicked the phenotype of EVI1 overexpression, similarly conferring partial resistance to antileukemic drugs.


Asunto(s)
Apoptosis/efectos de los fármacos , Inhibidor p21 de las Quinasas Dependientes de la Ciclina/metabolismo , Proteínas de Unión al ADN/metabolismo , Resistencia a Antineoplásicos , Leucemia Mieloide Aguda/patología , Células Mieloides/efectos de los fármacos , Factores de Transcripción/metabolismo , Regulación hacia Arriba/efectos de los fármacos , Animales , Antineoplásicos/farmacología , Antineoplásicos/uso terapéutico , Diferenciación Celular/efectos de los fármacos , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Proteínas de Unión al ADN/genética , Daunorrubicina/farmacología , Etopósido/farmacología , Femenino , Humanos , Leucemia Mieloide Aguda/tratamiento farmacológico , Leucemia Mieloide Aguda/genética , Leucemia Mieloide Aguda/metabolismo , Proteína del Locus del Complejo MDS1 y EV11 , Ratones , Células Mieloides/metabolismo , Células Mieloides/patología , Proto-Oncogenes/genética , Factores de Transcripción/genética
4.
Int J Oncol ; 40(6): 2131-9, 2012 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-22446629

RESUMEN

Investigating the bioactivity of traditional medical remedies under the controlled conditions of a laboratory is an option to find additional applications, novel formulations or lead structures for the development of new drugs. The present work analysed the anti­neoplastic activity of increasing polar extracts of the rainforest plant Critonia morifolia (Asteraceae) that has been successfully used as traditional remedy to treat various inflammatory conditions in the long-lasting medical tradition of the Central American Maya, which was here also confirmed in vitro. The apolar petroleum ether extract exhibited the most potent anti­proliferative and pro­apoptotic effects in HL­60 cells and triggered down-regulation of Cdc25C and cyclin D1 within 30 min followed by the inhibition of c-Myc expression and the onset of caspase-3 activation within 2 h. Subsequent to these very rapid molecular responses Chk2 and H2AX became phosphorylated (γ­H2AX) after 4 h. Analysis of the cell cycle distribution showed an accumulation of cells in the G2-M phase within 8 h and after 24 h in S-phase. This was temporally paralleled by the down-regulation of Cdc25A, Cdc25B, Wee1 and Akt. Therefore, the attenuation of cell cycle progression in the G2-M phase was consistent with the known role of Chk2 for G2-M arrest and with the role of Cdc25B in S-phase progression. These findings suggest the presence of two distinct active principles in the petroleum ether extract of C. moriflia. These facilitated the strong apoptotic response evidenced by the rapid activation of caspase-3 that was later enforced by the inhibition of the survival kinase Akt. Importantly, the efficient down-regulation of Akt, which is successfully tested in current clinical trials, is a unique property of C. morifolia.


Asunto(s)
Antineoplásicos/farmacología , Apoptosis/efectos de los fármacos , Asteraceae/química , Proteínas de Ciclo Celular/metabolismo , Extractos Vegetales/farmacología , Alcanos/química , Ciclo Celular/efectos de los fármacos , Puntos de Control del Ciclo Celular , Proteínas de Ciclo Celular/genética , Proliferación Celular/efectos de los fármacos , Ciclina D1/genética , Ciclina D1/metabolismo , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Células HL-60 , Humanos , Proteínas Proto-Oncogénicas c-akt/genética , Proteínas Proto-Oncogénicas c-akt/metabolismo , Proteínas Proto-Oncogénicas c-myc/genética , Proteínas Proto-Oncogénicas c-myc/metabolismo , Solventes/química , Fosfatasas cdc25/genética , Fosfatasas cdc25/metabolismo
5.
Toxicol Lett ; 205(2): 173-82, 2011 Aug 28.
Artículo en Inglés | MEDLINE | ID: mdl-21704138

RESUMEN

Several lines of evidence suggest that besides antioxidant also prooxidant properties are crucially involved in cytotoxic and protective activities of the major green tea catechin epigallocatechin-3-gallate (EGCG) in vitro (Elbling et al., 2011). Furthermore recent data suggest that EGCG induces oxidative stress also in vivo (Li et al., 2010). Here we set out to identify factors modulating cellular effects of EGCG in vitro. Using the HaCat keratinocytes model, we demonstrate that the cytotoxic, genotoxic and signal-activating effects of EGCG are significantly dependent on the ratio of cell number to working volume. Treatment with identical EGCG concentrations at altered experimental settings resulted in IC(50) values differing up to orders of magnitude and could even exert contradictory effects. This effect was based on cell-mediated clearance of autooxidation-derived H(2)O(2) from the supernatant. In order to estimate EGCG/H(2)O(2) concentrations equally effective under different settings, we have rationally derived and experimentally verified a simple algorithm relating concentration, working volume, cell number and - indirectly - exposure time. Algorithm application resulted in similar H(2)O(2) clearance curves from cell supernatants as well as comparable EGCG/H(2)O(2) effects at different settings. Our results demonstrate the importance of standardized experimental settings when investigating cytotoxic and/or beneficial effects of autooxidizing compounds.


Asunto(s)
Catequina/análogos & derivados , Peróxido de Hidrógeno/metabolismo , Peróxido de Hidrógeno/toxicidad , Queratinocitos/efectos de los fármacos , Mutágenos/toxicidad , Pruebas de Toxicidad/métodos , Algoritmos , Western Blotting , Catequina/toxicidad , Recuento de Células , Técnicas de Cultivo de Célula , Línea Celular , Supervivencia Celular/efectos de los fármacos , Interpretación Estadística de Datos , Relación Dosis-Respuesta a Droga , Humanos , Queratinocitos/citología , Queratinocitos/metabolismo , Oxidación-Reducción , Estrés Oxidativo/efectos de los fármacos , Factores de Tiempo , Pruebas de Toxicidad/normas
6.
Free Radic Biol Med ; 49(9): 1444-52, 2010 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-20708679

RESUMEN

The beneficial health effects of (-)-epigallocatechin-3-gallate (EGCG), the main catechin of green tea, have been attributed to complex interactions with a focus on antioxidative properties. Susceptibility to autoxidation and production of cytotoxic reactive oxygen species (ROS), mostly H(2)O(2), have been suggested to occur in vitro but also in vivo. In this study, we address whether autoxidation-derived H(2)O(2) may be involved in the cytoprotective effects of EGCG. To that end we investigated keratinocyte-derived HaCat and HL-60 promyelocytic leukemia cells with significantly different sensitivities to H(2)O(2) (IC(50) 117.3 versus 58.3 µM, respectively) and EGCG (134.1 versus 84.1 µM). HaCat cells significantly resisted cytotoxicity and DNA damage based on enhanced H(2)O(2) clearance, improved DNA repair, and reduced intracellular ROS generation. Cumulative versus bolus EGCG and H(2)O(2) treatment and H(2)O(2) pretreatment before subsequent high-dose EGCG and vice versa significantly reduced DNA damage and cytotoxicity in HaCat cells only. Addition of catalase abolished the protective activities of low-dose H(2)O(2) and EGCG. In summary, our data suggest that autoxidative generation of low-dose H(2)O(2) is a significant player in the cell-type-specific cytoprotection mediated by EGCG and support the hypothesis that regular green tea consumption can contribute as a pro-oxidant to increased resistance against high-dose oxidative stressors.


Asunto(s)
Antioxidantes/farmacología , Catequina/análogos & derivados , Citoprotección , Queratinocitos/efectos de los fármacos , Estrés Oxidativo , Apoptosis/efectos de los fármacos , Catalasa/farmacología , Catequina/farmacología , Línea Celular , Daño del ADN/efectos de los fármacos , Humanos , Peróxido de Hidrógeno/metabolismo , Queratinocitos/metabolismo , Queratinocitos/patología , Oxidación-Reducción/efectos de los fármacos
7.
Carcinogenesis ; 31(12): 2074-81, 2010 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19696164

RESUMEN

Estrogenic procarcinogenic effects of piceatannol (PIC) contrast reports about anticarcinogenic activities of PIC. To explain this contradiction, we investigated PIC in estrogen-dependent MCF-7 breast cancer cells and elucidated those cellular mechanisms that correlated with the observed cell effects induced by PIC. Low PIC concentrations (50 nM) induced c-Myc that depended on progesterone receptor (PR) and estrogen receptor (ER). PR-mediated c-Myc induction by PIC was independent of nuclear PR activity but depended on mitogen-activated protein kinase (MAPK) signaling and was associated with an acceleration of cancer cell proliferation. In contrast, 25 µM PIC inhibited deoxynucleotide triphosphate synthesis, activated Chk2 and p38-MAPK and this was accompanied by an attenuation of cancer cell growth. Apoptosis was most probably inhibited due to activation of Akt; however, high PIC concentrations (>100 µM) permitted apoptosis-like cell death in consequence to disruption of orchestrated mitotic signaling. The presented results show for the first time that nanomolar PIC concentrations signal through PR and Erk1/2 and provide a mechanistic explanation why moderate wine consumption-but not other alcoholic beverages-increases the breast cancer risk in women. In contrast, higher PIC concentrations in the micromolar range are considered for adjuvant anticancer therapeutic concepts.


Asunto(s)
Anticarcinógenos/farmacología , Neoplasias de la Mama/inducido químicamente , Neoplasias de la Mama/prevención & control , Carcinógenos/toxicidad , Estilbenos/farmacología , Estilbenos/toxicidad , Animales , Apoptosis/efectos de los fármacos , Células CHO , Línea Celular Tumoral , Cricetinae , Cricetulus , Relación Dosis-Respuesta a Droga , Quinasas MAP Reguladas por Señal Extracelular/fisiología , Femenino , Genes myc , Humanos , Receptores de Estrógenos/fisiología , Receptores de Progesterona/fisiología , Vino
8.
J Leukoc Biol ; 86(4): 813-22, 2009 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-19605700

RESUMEN

The oncogene EVI1 has been implicated in the etiology of AML and MDS. Although AML cells are characterized by accelerated proliferation and differentiation arrest, MDS cells hyperproliferate when immature but fail to differentiate later and die instead. In agreement with its roles in AML and in immature MDS cells, EVI1 was found to stimulate cell proliferation and inhibit differentiation in several experimental systems. In contrast, the variant protein MDS1/EVI1 caused the opposite effect in some of these assays. In the present study, we expressed EVI1 and MDS1/EVI1 in a tetracycline-regulable manner in the human myeloid cell line U937. Induction of either of these proteins caused cells to accumulate in the G(0)/G(1)-phase of the cell cycle and moderately increased the rate of spontaneous apoptosis. However, when EVI1- or MDS1/EVI1-expressing cells were induced to differentiate, they massively succumbed to apoptosis, as reflected by the accumulation of phosphatidylserine in the outer leaflet of the plasma membrane and increased rates of DNA fragmentation. In summary, these data show that inducible expression of EVI1 in U937 cells causes phenotypes that may be relevant for its role in MDS and provides a basis for further investigation of its contribution to this fatal disease.


Asunto(s)
Diferenciación Celular , Proteínas de Unión al ADN/biosíntesis , Fase G1 , Síndromes Mielodisplásicos/metabolismo , Células Mieloides/metabolismo , Fase de Descanso del Ciclo Celular , Factores de Transcripción/biosíntesis , Apoptosis , Fragmentación del ADN , Proteínas de Unión al ADN/genética , Humanos , Leucemia Mieloide Aguda/genética , Leucemia Mieloide Aguda/metabolismo , Leucemia Mieloide Aguda/mortalidad , Proteína del Locus del Complejo MDS1 y EV11 , Síndromes Mielodisplásicos/genética , Síndromes Mielodisplásicos/patología , Células Mieloides/patología , Fosfatidilserinas/genética , Fosfatidilserinas/metabolismo , Proto-Oncogenes/genética , Factores de Transcripción/genética , Células U937
9.
Methods Mol Biol ; 515: 125-35, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19378114

RESUMEN

Expression of transgenes from adenovirus vectors has become an extremely important and widely used tool in experimental cancer research and many other areas in the life sciences. It needs to be kept in mind, however, that adenoviruses are human pathogens and avoiding exposure of laboratory personnel to infectious viral particles is therefore an important concern. This issue seems even more important when the transgenes expressed for experimental purposes include oncogenic sequences. Decontamination procedures are thus required, whenever laboratory experiments with adenovirus vectors are performed and the effectiveness of these procedures has to be established. While many reports exist on the decontamination of blood and pharmaceutical products, data on the stability of adenoviruses during experiments performed in most life science laboratories are very scarce. One reason for this is that many of the methods used for assessing viral decontamination are time consuming and laborious and cannot easily be incorporated into the broad range of experimental setups typically performed in the laboratory. In this chapter we describe a reliable, sensitive, and simple method for the assessment of adenovirus decontamination by the use of an adenovirus expressing green fluorescent protein (GFP). The GFP adenovirus is subjected to various test conditions and afterwards susceptible indicator cells are exposed to the recovered virions. GFP expression is detected by a combination of fluorescence microscopy and flow cytometry. The simplicity and flexibility of the method allows one to monitor viral decontamination during the different scenarios occurring in the life science laboratory.


Asunto(s)
Adenoviridae/genética , Adenoviridae/aislamiento & purificación , Citometría de Flujo/métodos , Vectores Genéticos/genética , Proteínas Fluorescentes Verdes/análisis , Proteínas Fluorescentes Verdes/metabolismo , Microscopía Fluorescente/métodos , Línea Celular , Genes Reporteros/genética , Proteínas Fluorescentes Verdes/genética , Humanos , Sensibilidad y Especificidad
10.
Anal Biochem ; 380(1): 146-8, 2008 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-18541133

RESUMEN

Baculoviruses are widely used for protein production in insect cells, and their potential for gene transfer to mammalian cells is increasingly being recognized. Here we describe a baculovirus vector with a bicistronic mammalian expression cassette and demonstrate its suitability for efficient transient and stable protein expression in human glioblastoma cells. Bicistronic baculovirus vectors are safe, cost efficient, and easy to produce; thus, they represent an excellent gene transfer system for mammalian cells.


Asunto(s)
Baculoviridae/genética , Regulación de la Expresión Génica , Vectores Genéticos/genética , Proteínas/genética , Animales , Línea Celular Tumoral , Técnicas de Transferencia de Gen , Glioblastoma/genética , Glioblastoma/metabolismo , Glioblastoma/patología , Humanos , Factores de Tiempo , Transducción Genética
11.
Ann N Y Acad Sci ; 1095: 45-52, 2007 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-17404016

RESUMEN

Roscovitine (ROSC), a potent cyclin-dependent kinase inhibitor (CDI), inactivates cyclin-dependent kinase (CDK)2 resulting in the arrest of human MCF-7 breast cancer cells in G2 phase of the cell cycle. We have recently observed a strong activation of wild-type (wt) p53 protein in human MCF-7 breast cancer cells upon treatment with ROSC implicating that upregulated p53 might additionally modulate the primary action of ROSC. ROSC stabilized wt p53 protein resulting in a marked extension of its half-life. Since ROSC exhibits low cytotoxicity, it seems to upregulate p53 protein in a way different from DNA damage. ROSC induced phosphorylation of p53 protein at serine 46. Therefore, we decided to examine whether other anticancer drugs are also able to induce phosphorylation of wt p53 protein at serine 46. Exposure of MCF-7 cells to doxorubicin (DOX) at doses inducing a strong G2 arrest resulted in a weak upregulation of p53. No site-specific phosphorylation of p53 at serine 46 was detected. These results indicate that p53 activation is dispensable for DOX-induced G2 arrest. Moreover, the pattern of p53 phosphorylation strongly depends on the type of the stimulating factor.


Asunto(s)
Antineoplásicos/farmacología , Neoplasias de la Mama/metabolismo , Neoplasias de la Mama/patología , Serina/metabolismo , Proteína p53 Supresora de Tumor/metabolismo , Antibióticos Antineoplásicos/farmacología , Neoplasias de la Mama/tratamiento farmacológico , Ciclo Celular/efectos de los fármacos , Ciclo Celular/genética , Línea Celular Tumoral , Doxorrubicina/farmacología , Femenino , Humanos , Fosforilación/efectos de los fármacos , Purinas/farmacología , Roscovitina , Serina/genética , Proteína p53 Supresora de Tumor/genética
12.
Cancer Lett ; 245(1-2): 156-62, 2007 Jan 08.
Artículo en Inglés | MEDLINE | ID: mdl-16488533

RESUMEN

Gallic acid (GA) is a naturally occurring polyhydroxyphenolic compound and an excellent free radical scavenger. In this study, we examined its cytotoxic and biochemical effects on the human HL-60 promyelocytic leukemia cell line. GA caused a significant imbalance of deoxynucleosidetriphosphate (dNTP) pool sizes, indicating ribonucleotide reductase inhibition. Moreover, GA induced dose-dependent apoptosis in HL-60 cells (80microM GA led to the induction of apoptosis in 39% of cells) and attenuated progression from G0/G1 to the S phase of the cell cycle (60microM GA doubled the number of cells in G0/G1 phase from 22 to 44% when compared to untreated controls). We further determined IC(50) values of 3.5 and 4.4nM for the inhibition of cyclooxygenases I and II, respectively. When cells were simultaneously treated with GA and trimidox, another inhibitor of RR, highly synergistic growth inhibitory effects could be observed. Taken together, we identified novel biochemical effects of GA which could be the basis for further preclinical and in vivo studies.


Asunto(s)
Inhibidores de la Ciclooxigenasa/farmacología , Ácido Gálico/farmacología , Prostaglandina-Endoperóxido Sintasas/metabolismo , Ribonucleótido Reductasas/antagonistas & inhibidores , Adenosina Trifosfato/metabolismo , Apoptosis/efectos de los fármacos , Benzamidinas/química , Benzamidinas/farmacología , Ciclo Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Citidina Trifosfato/metabolismo , Relación Dosis-Respuesta a Droga , Inhibidores Enzimáticos/química , Inhibidores Enzimáticos/farmacología , Ácido Gálico/química , Guanosina Trifosfato/metabolismo , Células HL-60 , Humanos , Leucemia Promielocítica Aguda/enzimología , Leucemia Promielocítica Aguda/metabolismo , Leucemia Promielocítica Aguda/patología , Estructura Molecular , Ribonucleótido Reductasas/metabolismo , Nucleótidos de Timina/metabolismo
14.
Ann Nutr Metab ; 50(3): 282-9, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16508257

RESUMEN

BACKGROUND/AIMS: The aim of this work was to study the effects of daily yogurt consumption on the cellular immunity of young healthy women and to compare a conventional with a probiotic product. METHODS: 33 young healthy women (22-29 years) consumed 100 g/day of either probiotic or conventional commercially available yogurt for 2 weeks and 200 g/day for another 2 weeks followed by a 2-week washout period with no fermented food at all. Before the intervention and after each phase, a complete white blood count was done, the percentage of activated CD69+ T lymphocytes after stimulation of whole blood with pokeweed mitogen was determined as well as the natural cytotoxicity of peripheral blood mononuclear cells against a human erythroleukemic target cell line (K562). All analyses were done by flow cytometry. RESULTS: In the probiotic group only, the numbers of cytotoxic T lymphocytes (CD3+CD16+CD56+) increased significantly (+30.8% with p = 0.001, +22.1 and +32.7% with p = 0.002, for T2, T3 and T4 compared to T1). There were no major changes for other cell populations, and all remained within the physiological range. In both groups, the expression of CD69 on T lymphocytes increased after yogurt consumption, especially on CD8+ (conventional: T2 +23%, T3 +27.2%, probiotic: T2 +15.7%; T3 +10.8% compared to T1) and to a lesser extent on CD4+ (conventional: T2 +7.7%, T3 +14.9%, probiotic: T2 +4% compared to T1. The cytotoxic activity also augmented following the intake, this effect persisting after cessation of consumption. However, there were no significant differences between the probiotic and the conventional yogurt group. CONCLUSION: Daily yogurt intake has a stimulating effect on cellular immune functions, but in this study the probiotic product did not perform better than the traditional one.


Asunto(s)
Inmunidad Celular/efectos de los fármacos , Recuento de Linfocitos , Probióticos , Yogur , Adulto , Antígenos CD , Antígenos de Diferenciación de Linfocitos T , Estudios Cruzados , Femenino , Citometría de Flujo , Humanos , Lectinas Tipo C , Recuento de Leucocitos , Activación de Linfocitos/efectos de los fármacos , Factores de Tiempo , Resultado del Tratamiento
15.
Anticancer Res ; 25(6C): 4673-8, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16334159

RESUMEN

BACKGROUND: The impact of radiotherapy alone (RT-alone) and radiotherapy plus concurrent chemotherapy with cisplatin (RT-CHT) was determined for lymphocyte subpopulations in cervical cancer patients. MATERIALS AND METHODS: Thirty-four women were treated either with RT-alone (n=14) or RT-CHT (n=20). Peripheral lymphocytes were collected before, immediately after and 6, 12 and 24 weeks after completion of treatment. Flow cytometric analysis included total T-cells, T-helper-cells, T-suppressor-cells, T-cytotoxic-cells, NK-cells, B-cells and the CD4+/CD8+ratio. RESULTS: Twenty-four weeks after treatment, B-cells had recovered to pretreatment levels whereas total lymphocyte counts, T-helper and T-cytotoxic-cells were still significantly reduced in both groups. In contrast, T-suppressor-cells and NK-cells had recovered to pretreatment levels only in patients who received RT-alone and were still significantly reduced in patients who received RT-CHT. CONCLUSION: RT-alone and RT-CHT induce a significant and prolonged suppression of all lymphocyte subpopulations. RT-CHT, but not RT-alone, causes a prolonged suppression of NK-cells and T-suppressor cells.


Asunto(s)
Cisplatino/uso terapéutico , Subgrupos Linfocitarios/efectos de los fármacos , Subgrupos Linfocitarios/efectos de la radiación , Neoplasias del Cuello Uterino/inmunología , Neoplasias del Cuello Uterino/terapia , Adulto , Anciano , Anciano de 80 o más Años , Antineoplásicos/uso terapéutico , Linfocitos B/efectos de los fármacos , Linfocitos B/inmunología , Linfocitos B/efectos de la radiación , Relación CD4-CD8 , Terapia Combinada , Femenino , Humanos , Persona de Mediana Edad , Estadificación de Neoplasias , Estudios Prospectivos , Linfocitos T/efectos de los fármacos , Linfocitos T/inmunología , Linfocitos T/efectos de la radiación , Neoplasias del Cuello Uterino/tratamiento farmacológico , Neoplasias del Cuello Uterino/radioterapia
16.
Exp Biol Med (Maywood) ; 230(2): 144-9, 2005 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-15673563

RESUMEN

Avemar (MSC) is a nontoxic fermented wheat germ extract demonstrated to have antitumor effects. Avemar has the potential to significantly improve the survival rate in patients suffering from malignant colon tumors. We studied its effects in the HT-29 human colon carcinoma cell line. Avemar had an inhibiting effect on colonies of HT-29 cells with an IC50 value of 118 microg/ml (7 days of incubation); this value could be decreased to 100 and 75 microg/ml in the presence of vitamin C. In the cell line examined, Avemar induced both necrosis and apoptosis, as demonstrated by Hoechst/propidium iodide staining. The incubation of cells with 3200 microg/ml Avemar for 24 hrs caused necrosis in 28% and the induction of apoptosis in 22% of the cells. Avemar inhibited the cell-cycle progression of HT-29 cells in the G1 phase of the cell cycle. In addition, Avemar inhibited the activity of the key enzyme of de novo DNA synthesis, ribonucleotide reductase. In addition, we determined the effects of Avemar on the activity of cyclooxygenase-1 and -2. Both enzymes were significantly inhibited by Avemar with IC50 values of 100 and 300 microg/ml, respectively. We outline new explanations for its antitumor activity, which might serve as the basis for further studies using Avemar.


Asunto(s)
Extractos Vegetales/farmacología , Apoptosis , Ácido Ascórbico/farmacología , Ciclo Celular , Línea Celular Tumoral , Ciclooxigenasa 1 , Ciclooxigenasa 2 , ADN/metabolismo , Fase G1 , Humanos , Concentración 50 Inhibidora , Proteínas de la Membrana , Necrosis , Propidio/farmacología , Prostaglandina-Endoperóxido Sintasas/metabolismo , Ribonucleótido Reductasas/metabolismo , Triticum/metabolismo
17.
Cell Stress Chaperones ; 8(3): 249-57, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-14984058

RESUMEN

Hsp27 is considered a potential marker for cell differentiation in diverse tissues. Several aspects linked to the differentiation process and to the transition from high to low metastatic potential were analyzed in melanoma cells transfected with Hsp27. E-cadherin plays a central role in cell differentiation, migration, and normal development. Loss of expression or function of E-cadherin has been documented in a variety of human malignancies. We observed by fluorescence-activated cell sorter (FACS) as well as immunofluorescence (IF) analysis a pronounced expression of E-cadherin in Hsp27-transfected A375 melanoma cells compared with control melanoma cells. The expression of the adhesion molecule MUC18/MCAM correlates directly with the metastatic potential of melanoma cells. In contrast to wild-type and neotransfected melanoma cells, in Hsp27-transfected cells the expression of MUC18/MCAM could not be detected by FACS and IF analysis. The plasminogen activator (PA) system plays a central role in mediating extracellular proteolysis and also in nonproteolytic events such as cell adhesion, migration, and transmembrane signaling. Hsp27 transfectants revealed elevated messenger ribonucleic acid expression of the urokinase-type PA (uPA) and its inhibitor, PA inhibitor type 1, which might indicate a neutralization effect of the proteolytic activity of uPA. Control cells failed to express both these molecules. The influence of Hsp27 expression on uPA activity and the involvement of E-cadherin could be demonstrated by use of anti-E-cadherin-blocking antibody. Our data provide evidence for an inhibitory-regulatory role of Hsp27 in tumor progression as found in our system.


Asunto(s)
Antígenos CD , Cadherinas/metabolismo , Proteínas de Choque Térmico/metabolismo , Melanoma/metabolismo , Glicoproteínas de Membrana/metabolismo , Moléculas de Adhesión de Célula Nerviosa , Activadores Plasminogénicos/metabolismo , Neoplasias Cutáneas/metabolismo , Secuencia de Bases , Biomarcadores de Tumor/análisis , Antígeno CD146 , Línea Celular Tumoral , Técnica del Anticuerpo Fluorescente , Regulación de la Expresión Génica , Proteínas de Choque Térmico/análisis , Proteínas de Choque Térmico/genética , Humanos , Melanoma/genética , Datos de Secuencia Molecular , ARN/metabolismo , Neoplasias Cutáneas/genética
18.
Cell Stress Chaperones ; 7(1): 107-17, 2002 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11892982

RESUMEN

In the present study we used a murine melanoma model to investigate the effect of the 25-kDa heat shock protein (Hsp25) on natural killer (NK) cytotoxicity. The melanoma lines K1735-C123 (low metastatic potential) and K1735-M2 (high metastatic potential) were transfected with hsp25 and a control plasmid. Highly purified interleukin (IL)-2-stimulated DX-5+ NK cells showed enhanced lysis of Hsp25-overexpressing K1735-C123 targets in comparison with controls. In contrast, there was no difference in susceptibility to lysis by purified IL-2-stimulated DX-5+ NK cells between Hsp25-overexpressing and control-transfected K1735-M2 targets. Fluorescence-activated cell sorter analysis revealed that Hsp25 is displayed on the cell surface independently of Hsp25 overexpression and metastatic phenotype. Thus, surface localization of Hsp25 does not correlate with the target cell susceptibility to killing. To sum up, a cytoplasmic overexpression of Hsp25 is associated with an increased susceptibility to lysis by DX-5+ NK cells in the low-metastatic murine melanoma model investigated.


Asunto(s)
Proteínas de Choque Térmico , Células Asesinas Naturales/inmunología , Melanoma , Proteínas de Neoplasias/genética , Proteínas de Neoplasias/inmunología , Animales , Pruebas Inmunológicas de Citotoxicidad , Citometría de Flujo , Regulación Neoplásica de la Expresión Génica/inmunología , Antígenos de Histocompatibilidad Clase II/metabolismo , Ratones , Ratones Endogámicos C3H , Chaperonas Moleculares , Metástasis de la Neoplasia/inmunología , Células Tumorales Cultivadas/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...